ArticleScientific reports2025
Young green quinoa as a sustainable functional crop with anti-inflammatory effects in macrophage cells.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bioactive Peptides from Andean Crops: Lactic Acid Bacteria Fermentation, Complementary Proteolysis, and Biological Activities.Foods (Basel, Switzerland) · 2026Review
- Physiological responses of young vegetative quinoa (Frontiers in plant science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Current staple crops such as rice, wheat, and maize dominate food systems but lack climate resilience, necessitating a shift toward nutrient-rich, sustainable alternatives. Chenopodium quinoa, (C. quinoa) has gained global recognition for its adaptability and nutritional value. However, while quinoa grains have been extensively studied, young green quinoa (YGQ) leaves remain underexplored despite their potential to enhance both agricultural sustainability and human health. This study investigates the anti-inflammatory properties of YGQ leaves extracts from eight quinoa accessions cultivated during the summer. Using lipopolysaccharide (LPS)-activated mouse macrophage cells (RAW264.7), we assessed the inhibition of key pro-inflammatory cytokines, tumor necrosis factor (TNF)-α and Interleukin (IL)-6. Four types of extracts-Ethanol:Water (70:30) (ETDW), Ethanol (ET), Ethyl Acetate (EA), and Hexane (HE) were prepared, revealing significant and specific IL-6 inhibition, with ETDW exhibiting the highest suppressive effect (73-100%). LC-MS/MS analysis identified flavonoids as the likely bioactive compounds responsible for this activity. Importantly, toxicity assays confirmed the extracts' safety. These findings position YGQ leaves as a valuable natural source of bioactive compounds with potential applications in functional foods, which offer health benefits beyond basic nutrition by targeting the prevention of noncommunicable diseases and chronic inflammatory conditions. Furthermore, integrating YGQ leaves into food systems could support sustainable agriculture, as quinoa is a climate-resilient crop, providing dual benefits for public health and food security.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.